129 related articles for article (PubMed ID: 34251002)
21. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.
Yue PJ; He L; Qiu SW; Li Y; Liao YJ; Li XP; Xie D; Peng Y
Mol Cancer; 2014 Aug; 13():191. PubMed ID: 25128329
[TBL] [Abstract][Full Text] [Related]
22. Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells.
Koh YH; Moochhala S; Bhatia M
J Cell Mol Med; 2012 Jul; 16(7):1582-92. PubMed ID: 22040127
[TBL] [Abstract][Full Text] [Related]
23. Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor.
McConalogue K; Déry O; Lovett M; Wong H; Walsh JH; Grady EF; Bunnett NW
J Biol Chem; 1999 Jun; 274(23):16257-68. PubMed ID: 10347182
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
Meng F; DeMorrow S; Venter J; Frampton G; Han Y; Francis H; Standeford H; Avila S; McDaniel K; McMillin M; Afroze S; Guerrier M; Quezada M; Ray D; Kennedy L; Hargrove L; Glaser S; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G759-68. PubMed ID: 24603459
[TBL] [Abstract][Full Text] [Related]
25. Real-time near-infrared bioimaging of a receptor-targeted cytotoxic dendritic theranostic agent.
Wu J; Zhou Y; Li S; Qu D; Zhu WH; Tian H
Biomaterials; 2017 Mar; 120():1-10. PubMed ID: 28011190
[TBL] [Abstract][Full Text] [Related]
26. Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor.
Tansky MF; Pothoulakis C; Leeman SE
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10691-6. PubMed ID: 17563389
[TBL] [Abstract][Full Text] [Related]
27. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
[TBL] [Abstract][Full Text] [Related]
28. Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing Cancers.
Kanduluru AK; Low PS
Mol Pharm; 2017 Nov; 14(11):3859-3865. PubMed ID: 28969417
[TBL] [Abstract][Full Text] [Related]
29. A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas.
Akazawa T; Kwatra SG; Goldsmith LE; Richardson MD; Cox EA; Sampson JH; Kwatra MM
J Neurochem; 2009 May; 109(4):1079-86. PubMed ID: 19519779
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of substance P transport across the blood-brain barrier.
Chappa AK; Audus KL; Lunte SM
Pharm Res; 2006 Jun; 23(6):1201-8. PubMed ID: 16729222
[TBL] [Abstract][Full Text] [Related]
31. Substance P and the neurokinin-1 receptor expression in dog ileum with and without inflammation.
Polidoro G; Giancola F; Fracassi F; Pietra M; Bettini G; Asti M; Chiocchetti R
Res Vet Sci; 2017 Oct; 114():297-307. PubMed ID: 28628846
[TBL] [Abstract][Full Text] [Related]
32. Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex.
Wang J; Lei Y; Xie C; Lu W; Yan Z; Gao J; Xie Z; Zhang X; Liu M
Int J Pharm; 2013 Dec; 458(1):48-56. PubMed ID: 24144951
[TBL] [Abstract][Full Text] [Related]
33. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298
[TBL] [Abstract][Full Text] [Related]
34. New insight into the role of substance P/neurokinin-1 receptor system in breast cancer progression and its crosstalk with microRNAs.
Ebrahimi S; Javid H; Alaei A; Hashemy SI
Clin Genet; 2020 Oct; 98(4):322-330. PubMed ID: 32266968
[TBL] [Abstract][Full Text] [Related]
35. Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization.
Arapulisamy O; Mannangatti P; Jayanthi LD
J Biol Chem; 2013 Oct; 288(40):28599-610. PubMed ID: 23979140
[TBL] [Abstract][Full Text] [Related]
36. β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G
Zhang YX; Li XF; Yuan GQ; Hu H; Song XY; Li JY; Miao XK; Zhou TX; Yang WL; Zhang XW; Mou LY; Wang R
J Biol Chem; 2017 May; 292(21):8933-8947. PubMed ID: 28341744
[TBL] [Abstract][Full Text] [Related]
37. An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells.
Rizk SS; Luchniak A; Uysal S; Brawley CM; Rock RS; Kossiakoff AA
Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11011-5. PubMed ID: 19549879
[TBL] [Abstract][Full Text] [Related]
38. The role of substance P in the marginal division of the neostriatum in learning and memory is mediated through the neurokinin 1 receptor in rats.
Liu XM; Shu SY; Zeng CC; Cai YF; Zhang KH; Wang CX; Fang J
Neurochem Res; 2011 Oct; 36(10):1896-902. PubMed ID: 21611833
[TBL] [Abstract][Full Text] [Related]
39. A monoclonal antibody directed against the neurokinin-1 receptor contains a peptide sequence with similar hydropathy and functional properties to substance P, the natural ligand for the receptor.
Sagot MA; Wijkhuisen A; Créminon C; Tymciu S; Frobert Y; Turbica I; Grassi J; Couraud JY; Boquet D
Mol Immunol; 2000 Jun; 37(8):423-33. PubMed ID: 11090877
[TBL] [Abstract][Full Text] [Related]
40. The neuropeptide substance P/neurokinin-1 receptor system and diabetes: From mechanism to therapy.
Kokabi F; Ebrahimi S; Mirzavi F; Ghiasi Nooghabi N; Hashemi SF; Hashemy SI
Biofactors; 2023; 49(3):534-559. PubMed ID: 36651605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
